非小细胞肺癌患者的新辅助免疫治疗——新时代即将来临？ - Suppr

Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung Cancer-Is a New Era Coming?

作者信息

Zhang Bo, Zhong Hua, Han Baohui

机构信息

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

JAMA Oncol. 2023 Mar 1;9(3):301-302. doi: 10.1001/jamaoncol.2022.6898.

DOI:10.1001/jamaoncol.2022.6898

PMID:36701143

Abstract

摘要

相似文献

Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung Cancer-Is a New Era Coming?

JAMA Oncol. 2023 Mar 1;9(3):301-302. doi: 10.1001/jamaoncol.2022.6898.

[Progress of Neoadjuvant Immunotherapy for Non-small Cell Lung Cancer].

Zhongguo Fei Ai Za Zhi. 2022 Jul 20;25(7):524-533. doi: 10.3779/j.issn.1009-3419.2022.101.29.

KEYNOTE-024: Unlocking a pathway to lung cancer cure?

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1777-1780. doi: 10.1016/j.jtcvs.2017.10.155. Epub 2017 Dec 23.

There and back again: An immunotherapy tale.

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1771-1774. doi: 10.1016/j.jtcvs.2017.11.102. Epub 2017 Dec 23.

[Progress of immune checkpoint inhibitors in neoadjuvant therapy of non-small cell lung cancer].

Zhonghua Wai Ke Za Zhi. 2019 Nov 1;57(11):872-877. doi: 10.3760/cma.j.issn.0529-5815.2019.11.015.

Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.

J Thorac Cardiovasc Surg. 2020 Nov;160(5):1376-1382. doi: 10.1016/j.jtcvs.2020.05.119. Epub 2020 Jul 5.

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial.

BMC Cancer. 2019 May 2;19(1):413. doi: 10.1186/s12885-019-5624-2.

Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer.

J Thorac Cardiovasc Surg. 2023 Jun;165(6):1949-1953. doi: 10.1016/j.jtcvs.2022.10.047. Epub 2022 Nov 4.

[Operability and Pathological Response of Non-Small Cell Lung Cancer (NSCLC) after Neoadjuvant Therapy with Immune Checkpoint Inhibition].

Pneumologie. 2020 Nov;74(11):766-772. doi: 10.1055/a-1199-2029. Epub 2020 Aug 20.

The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.

Clin Lung Cancer. 2022 Mar;23(2):108-115. doi: 10.1016/j.cllc.2021.11.003. Epub 2021 Nov 11.

引用本文的文献

Optimizing the spatial immune landscape of CD103CD8 tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy.

Cell Oncol (Dordr). 2024 Oct;47(5):1957-1971. doi: 10.1007/s13402-024-00980-4. Epub 2024 Aug 19.

Can Molecular Biomarkers be Utilized to Determine Appropriate Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC)?

J Cell Immunol. 2024;6(2):82-86. doi: 10.33696/immunology.6.193.

Efficacy and safety of different cycles of neoadjuvant immunotherapy in resectable non-small cell lung cancer: A systematic review and meta-analysis.

Heliyon. 2024 May 22;10(11):e31549. doi: 10.1016/j.heliyon.2024.e31549. eCollection 2024 Jun 15.

Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models.

Breast Cancer. 2024 May;31(3):371-381. doi: 10.1007/s12282-024-01543-z. Epub 2024 Jan 30.

Efficacy, safety, and survival of neoadjuvant immunochemotherapy in operable non-small cell lung cancer: a systematic review and meta-analysis.

Front Immunol. 2023 Dec 1;14:1273220. doi: 10.3389/fimmu.2023.1273220. eCollection 2023.

Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study.

Hum Vaccin Immunother. 2023 Dec 15;19(3):2285902. doi: 10.1080/21645515.2023.2285902. Epub 2023 Nov 27.

Surgery for Non-Small Cell Lung Cancer in the Personalized Therapy Era.

Curr Oncol. 2023 Aug 21;30(8):7773-7776. doi: 10.3390/curroncol30080563.

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research.

Discov Oncol. 2023 Jun 7;14(1):91. doi: 10.1007/s12672-023-00698-z.

Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer.

J Transl Med. 2023 May 12;21(1):320. doi: 10.1186/s12967-023-04154-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Neoadjuvant Immunotherapy for Patients With Non-Small Cell Lung Cancer-Is a New Era Coming?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献